TSPAN12 Gene Exudative vitreoretinopathy type 5 Genetic Test
At DNA Labs UAE, we offer the TSPAN12 Gene Exudative vitreoretinopathy type 5 Genetic Test. This test is designed to diagnose and analyze the rare genetic disorder known as Exudative vitreoretinopathy type 5 (EVR5).
Test Details
EVR5 is a genetic disorder that affects the development and function of the retina, the tissue at the back of the eye. It is caused by mutations in the TSPAN12 gene, which is responsible for the formation and maintenance of blood vessels in the retina.
Our TSPAN12 Gene Exudative vitreoretinopathy type 5 Genetic Test utilizes NGS (next-generation sequencing) technology. This advanced DNA analysis method allows for the simultaneous analysis of multiple genes, making it a powerful tool for genetic diagnosis and research.
Test Components and Price
The TSPAN12 Gene Exudative vitreoretinopathy type 5 Genetic Test is priced at 4400.0 AED. The test requires a blood or extracted DNA sample, or one drop of blood on an FTA card.
Report Delivery and Method
After the sample is collected, the test results will be delivered within 3 to 4 weeks. The NGS technology is used to analyze the sample and compare the DNA data to a reference genome to identify any genetic variations or mutations.
Test Type and Doctor
The TSPAN12 Gene Exudative vitreoretinopathy type 5 Genetic Test falls under the category of Ophthalmology Disorders. It is recommended to consult with an Ophthalmologist for this test.
Test Department and Pre Test Information
The TSPAN12 Gene Exudative vitreoretinopathy type 5 Genetic Test is conducted in the Genetics department. It is important to provide the clinical history of the patient who is going for the test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the TSPAN12 Gene Exudative vitreoretinopathy type 5.
Benefits and Applications
NGS genetic testing for EVR5 not only helps in diagnosing the condition but also enables the screening of family members who may be at risk of developing the disorder. Early detection and treatment can be made possible with this test, leading to personalized treatment plans for affected individuals and their families.
Overall, the TSPAN12 Gene Exudative vitreoretinopathy type 5 Genetic Test offered at DNA Labs UAE is a valuable tool for improving our understanding of this rare genetic disorder and providing accurate diagnoses and personalized treatment plans.
| Test Name | TSPAN12 Gene Exudative vitreoretinopathy type 5 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ophthalmology Disorders |
| Doctor | Ophthalmologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TSPAN12 Gene Exudative vitreoretinopathy type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TSPAN12 Gene Exudative vitreoretinopathy type 5 NGS Genetic DNA Test gene TSPAN12 |
| Test Details | Exudative vitreoretinopathy type 5 (EVR5) is a rare genetic disorder that affects the development and function of the retina, the tissue at the back of the eye that senses light and sends visual signals to the brain. EVR5 is caused by mutations in the TSPAN12 gene, which provides instructions for making a protein that is involved in the formation and maintenance of blood vessels in the retina. NGS (next-generation sequencing) genetic testing is a type of DNA analysis that can detect mutations in the TSPAN12 gene and other genes that are associated with EVR5. NGS technology allows for the simultaneous analysis of multiple genes, making it a powerful tool for genetic diagnosis and research. NGS genetic testing for EVR5 typically involves the analysis of a blood or saliva sample from the patient. The DNA in the sample is sequenced, and the resulting data is compared to a reference genome to identify any genetic variations or mutations. If a mutation in the TSPAN12 gene is detected, the patient may be diagnosed with EVR5. NGS genetic testing can also be used to screen family members of a person with EVR5 for the same mutation. This can help identify individuals who may be at risk of developing the condition and enable early detection and treatment. Overall, NGS genetic testing for EVR5 is a valuable tool for improving our understanding of this rare genetic disorder and for providing accurate diagnoses and personalized treatment plans for affected individuals and their families. |
